Tauns Laboratories, Inc. (JP:197A) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TAUNS Laboratories, Inc. has signed a Memorandum of Understanding with Roche Diagnostics K.K. to enter into a Master Transaction Agreement for the sale of TAUNS’ products, aiming to enhance business growth for both companies. The agreement will cover specific diagnostic products and is set to commence in January 2025.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.